In mouse models, removing the creatine transporter from dendritic cells reduces their survival, activation, and capacity to trigger T cell proliferation and cytokine release, indicating that creatine uptake is required for normal dendritic cell function in the tumor microenvironment.
See the scientific wording
Genetic deletion of the creatine transporter in dendritic cells impairs their survival, activation, and ability to stimulate T cell proliferation and cytokine production in mouse models, demonstrating that creatine uptake is necessary for optimal dendritic cell function in the tumor microenvironment.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman
When scientists gave mice extra creatine, their immune cells worked better against tumors — which suggests that these immune cells need creatine to function properly. So if they can't take in creatine, they probably can't work well either.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Dendritic cells in tumors take in creatine to make a molecule that keeps their energy supply stable. This energy powers their ability to wake up T cells, signal them to multiply, and tell them to attack cancer. Without creatine, dendritic cells run out of energy, stay inactive, and fail to trigger an immune response.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In mouse models, removing the creatine transporter from dendritic cells reduces their survival, activation, and capacity to trigger T cell proliferation and cytokine release, indicating that creatine uptake is required for normal dendritic cell function in the tumor microenvironment.
Mechanism
1 studyDendritic cells in tumors need creatine to keep their energy high. With enough energy, they wake up T cells to attack cancer. Without creatine, dendritic cells run out of power and cannot activate T cells at all.
Dendritic cells in tumors take in creatine to make a molecule that keeps their energy supply stable. This energy powers their ability to wake up T cells, signal them to multiply, and tell them to attack cancer. Without creatine, dendritic cells run out of energy, stay inactive, and fail to trigger an immune response.
Dendritic cells in the tumor microenvironment increase expression of the creatine transporter to enhance creatine uptake from the surrounding environment
Internalized creatine is converted to phosphocreatine, which rapidly regenerates ATP to maintain high energy levels during activation
Sustained ATP levels support energy-intensive processes including antigen processing, upregulation of co-stimulatory molecules, and inflammatory signaling
Activated dendritic cells present tumor antigens and deliver co-stimulatory signals to T cells, triggering their proliferation and effector function
T cells produce cytokines and cytotoxic molecules that target and destroy tumor cells
Evidence from Studies
Supporting (1)
Community contributions welcome
Unknown Title
When scientists gave mice extra creatine, their immune cells worked better against tumors — which suggests that these immune cells need creatine to function properly. So if they can't take in creatine, they probably can't work well either.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
Clinical support requires direct evidence. Mechanistic proxy and tangential studies contribute only to the mechanistic score.
- All linked studies are tangential or mechanistic proxies — no direct test of the claim has been found.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Genetic Deletion of Creatine Transporter in Dendritic Cells Across Mouse Tumor Models
Systematic review and meta-analysis of all peer-reviewed studies reporting genetic deletion of the creatine transporter in dendritic cells in mouse tumor models, measuring survival, activation markers, T cell proliferation, and cytokine production
Randomized Controlled Trial of Creatine Transporter Knockout vs Wild-Type Dendritic Cells in Murine Tumor Models
Randomized assignment of mice with dendritic cell-specific creatine transporter knockout versus wild-type controls, with tumor implantation, followed by measurement of dendritic cell survival, activation, T cell proliferation, and cytokine production over 14 days
Cohort Study Comparing Dendritic Cell Function in Mice with and without Creatine Transporter Expression in Tumor Microenvironments
Prospective cohort of tumor-bearing mice stratified by creatine transporter expression levels in dendritic cells, tracked over time for survival, activation, T cell proliferation, and cytokine production
In Vitro Study of Creatine Transporter Knockout in Dendritic Cells on T Cell Stimulation and Cytokine Production
Isolated dendritic cells from wild-type and creatine transporter knockout mice cultured with T cells, measuring proliferation and cytokine output in controlled media conditions over 48–72 hours
Animal Model Study of Dendritic Cell Creatine Transporter Deletion on Tumor Growth and Immune Response in Mice
Mouse model with dendritic cell-specific creatine transporter deletion, implanted with tumor cells, monitored for tumor growth, dendritic cell phenotype, T cell infiltration, and cytokine levels over 21 days